Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
130M
-
Number of holders
-
236
-
Total 13F shares, excl. options
-
112M
-
Shares change
-
-7.44M
-
Total reported value, excl. options
-
$968M
-
Value change
-
-$61.2M
-
Put/Call ratio
-
0.2
-
Number of buys
-
105
-
Number of sells
-
-108
-
Price
-
$8.61
Significant Holders of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) as of Q3 2022
267 filings reported holding NEO - NEOGENOMICS INC - Common Stock, par value $0.001 per share as of Q3 2022.
NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) has 236 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 112M shares
of 130M outstanding shares and own 86.81% of the company stock.
Largest 10 shareholders include BlackRock Inc. (21.1M shares), VANGUARD GROUP INC (13.2M shares), BROWN ADVISORY INC (6.18M shares), JANUS HENDERSON GROUP PLC (5.96M shares), STATE STREET CORP (4.22M shares), WELLINGTON MANAGEMENT GROUP LLP (3.21M shares), First Light Asset Management, LLC (2.72M shares), GOLDMAN SACHS GROUP INC (2.65M shares), T. Rowe Price Investment Management, Inc. (2.57M shares), and GEODE CAPITAL MANAGEMENT, LLC (2.35M shares).
This table shows the top 236 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.